Medtronic plc (MDT)

USD 80.03

(-1.65%)

Gross Profit Summary of Medtronic plc

  • Medtronic plc's latest annual gross profit in 2024 was 19.45 Billion USD , up 3.12% from previous year.
  • Medtronic plc's latest quarterly gross profit in 2024 FY was 19.45 Billion USD , down -5.14% from previous quarter.
  • Medtronic plc reported a annual gross profit of 20.5 Billion USD in annual gross profit 2023, down -4.8% from previous year.
  • Medtronic plc reported a annual gross profit of 21.54 Billion USD in annual gross profit 2022, up 9.71% from previous year.
  • Medtronic plc reported a quarterly gross profit of 5.07 Billion USD for 2024 Q1, down -8.81% from previous quarter.
  • Medtronic plc reported a quarterly gross profit of 5.22 Billion USD for 2024 Q2, up 2.94% from previous quarter.

Annual Gross Profit Chart of Medtronic plc (2024 - 1989)

Historical Annual Gross Profit of Medtronic plc (2024 - 1989)

Year Gross Profit Gross Profit Growth
2024 19.45 Billion USD 3.12%
2023 20.5 Billion USD -4.8%
2022 21.54 Billion USD 9.71%
2021 19.63 Billion USD 0.74%
2020 19.48 Billion USD -8.94%
2019 21.4 Billion USD 2.41%
2018 20.89 Billion USD 2.35%
2017 20.41 Billion USD 3.7%
2016 19.69 Billion USD 41.13%
2015 13.95 Billion USD 10.1%
2014 12.67 Billion USD 1.67%
2013 12.46 Billion USD 1.37%
2012 12.29 Billion USD 2.28%
2011 12.02 Billion USD 0.13%
2010 12 Billion USD 8.34%
2009 11.08 Billion USD 10.05%
2008 10.06 Billion USD 10.27%
2007 9.13 Billion USD 7.72%
2006 8.47 Billion USD 11.42%
2005 7.6 Billion USD 11.32%
2004 6.83 Billion USD 18.34%
2003 5.77 Billion USD 21.37%
2002 4.75 Billion USD 7.2%
2001 4.43 Billion USD 12.7%
2000 3.93 Billion USD 21.39%
1999 3.24 Billion USD 56.58%
1998 2.07 Billion USD 6.54%
1997 1.94 Billion USD 15.0%
1996 1.69 Billion USD 29.22%
1995 1.3 Billion USD 26.11%
1994 1.03 Billion USD 6.15%
1993 977.7 Million USD 14.42%
1992 854.5 Million USD 16.07%
1991 736.2 Million USD 21.85%
1990 604.2 Million USD 10.4%
1989 547.3 Million USD 15.88%

Peer Gross Profit Comparison of Medtronic plc

Name Gross Profit Gross Profit Difference
Abbott Laboratories 22.13 Billion USD 12.113%
Allurion Technologies Inc. 41.49 Million USD -46778.088%
Artivion, Inc. 229.17 Million USD -8388.236%
Avanos Medical, Inc. 379.7 Million USD -5023.255%
Butterfly Network, Inc. 16.85 Million USD -115306.977%
Butterfly Network, Inc. 16.85 Million USD -115306.977%
Bio-Rad Laboratories, Inc. 1.43 Billion USD -1259.07%
Boston Scientific Corporation 9.89 Billion USD -96.594%
Perspective Therapeutics, Inc. 1.63 Million USD -1190414.076%
CONMED Corporation 643.06 Million USD -2925.035%
Edwards Lifesciences Corporation 4.62 Billion USD -320.605%
Paragon 28, Inc. 172.79 Million USD -11158.11%
Glaukos Corporation 239.13 Million USD -8034.702%
Globus Medical, Inc. 1.02 Billion USD -1806.592%
Inspire Medical Systems, Inc. 528.22 Million USD -3582.725%
Integer Holdings Corporation 418.28 Million USD -4550.612%
Nevro Corp. 290.06 Million USD -6606.543%
Owlet, Inc. 22.58 Million USD -86024.762%
Penumbra, Inc. 682.64 Million USD -2749.659%
Vicarious Surgical Inc. -1.85 Million USD 1049344.876%
Smith & Nephew plc 3.7 Billion USD -425.615%
Sonendo, Inc. 10.72 Million USD -181330.703%
STERIS plc 2.23 Billion USD -770.771%
Stryker Corporation 13.05 Billion USD -48.974%
Vapotherm, Inc. 28.28 Million USD -68679.832%
Zimmer Biomet Holdings, Inc. 5.31 Billion USD -266.319%